Global Over-The-Counter Veterinary Drug Market Growth (Status and Outlook) 2023-2029

Global Over-The-Counter Veterinary Drug Market Growth (Status and Outlook) 2023-2029

Product Code:572119

Published Date: Jan 03,2023

Pages: 89

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Over-The-Counter (OTC) Veterinary Drugs, also termed as non-prescription drugs are drugs that are available without any prescription.

LPI (LP Information)' newest research report, the “Over-The-Counter Veterinary Drug Industry Forecast” looks at past sales and reviews total world Over-The-Counter Veterinary Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Over-The-Counter Veterinary Drug sales for 2023 through 2029. With Over-The-Counter Veterinary Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Over-The-Counter Veterinary Drug industry.

This Insight Report provides a comprehensive analysis of the global Over-The-Counter Veterinary Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Over-The-Counter Veterinary Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Over-The-Counter Veterinary Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Over-The-Counter Veterinary Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Over-The-Counter Veterinary Drug.

The global Over-The-Counter Veterinary Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Over-The-Counter Veterinary Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Over-The-Counter Veterinary Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Over-The-Counter Veterinary Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Over-The-Counter Veterinary Drug players cover Merck, Zoetis, Eli Lilly, Virbac, Bayer, Sanofi, Soparfin SCA, C. H. Boehringer Sohn and Dechra Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Over-The-Counter Veterinary Drug market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Topical Drug
    Oral Drug
    Injectable Drug

Segmentation by application
    Veterinary Hospital
    Veterinary Clinic
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Merck
    Zoetis
    Eli Lilly
    Virbac
    Bayer
    Sanofi
    Soparfin SCA
    C. H. Boehringer Sohn
    Dechra Pharmaceuticals